Pnserpin: a Novel Serine Protease Inhibitor from Extremophile Pyrobaculum Neutrophilum
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Secretory Proprotein Convertase Neural Apoptosis-Regulated Convertase 1 (NARC-1): Liver Regeneration and Neuronal Differentiation
The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiation Nabil G. Seidah*†, Suzanne Benjannet*, Louise Wickham*, Jadwiga Marcinkiewicz*, Ste´phanie Be´langer Jasmin‡, Stefano Stifani‡, Ajoy Basak§, Annik Prat*, and Michel Chre´ tien§ *Laboratory of Biochemical Neuroendocrinology, Clinical Research Institute of Montreal, 110 Pine Avenue West, Montreal, QC, H2W 1R7 Canada; ‡Montreal Neurological Institute, McGill University, Montreal, QC, H3A 2B4 Canada; and §Regional Protein Chemistry Center and Diseases of Aging Unit, Ottawa Health Research Institute, Ottawa Hospital, Civic Campus, 725 Parkdale Avenue, Ottawa, ON, K1Y 4E9 Canada Edited by Donald F. Steiner, University of Chicago, Chicago, IL, and approved December 5, 2002 (received for review September 10, 2002) Seven secretory mammalian kexin-like subtilases have been iden- LP251 (Eli Lilly, patent no. WO 02͞14358 A2) recently cloned tified that cleave a variety of precursor proteins at monobasic and by two pharmaceutical companies. NARC-1 was identified via dibasic residues. The recently characterized pyrolysin-like subtilase the cloning of cDNAs up-regulated after apoptosis induced by SKI-1 cleaves proproteins at nonbasic residues. In this work we serum deprivation in primary cerebellar neurons, whereas LP251 describe the properties of a proteinase K-like subtilase, neural was discovered via global cloning of secretory proteins. Aside apoptosis-regulated convertase 1 (NARC-1), representing the ninth from the fact that NARC-1 mRNA is expressed in liver ϾϾ member of the secretory subtilase family. Biosynthetic and micro- testis Ͼ kidney and that the gene localizes to human chromo- sequencing analyses of WT and mutant enzyme revealed that some 1p33-p34.3, no information is available on NARC-1 ac- human and mouse pro-NARC-1 are autocatalytically and intramo- tivity, cleavage specificity, cellular and tissue expression, and lecularly processed into NARC-1 at the (Y,I)VV(V,L)(L,M)2 motif, a biological function. -
Plasminogen Activator Inhibitor Type-1
PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1: structure-function studies and its use as a reference for intramolecular distance measurements by Peter Hägglöf Department of Medical Biochemistry and Biophysics Umeå University, Sweden Umeå 2004 1 Copyright 2003 Peter Hägglöf Printed in Sweden by VMC-KBC New Series No. 869; ISSN 0346-6612; ISBN 91-7305-571 2 TABLE OF CONTENTS ABBREVIATIONS 4 ABSTRACT 5 PREFACE 6 INTRODUCTION 7 1. General overview 7 2. Serine proteases 8 2.1 Plasmin 9 2.2 Urokinase-type plasminogen activator (uPA) 9 2.3 Tissue-type plasminogen activator (tPA) 10 3. Serpin structure 10 3.1 Introduction 11 3.2 Active form 11 3.3 Cleaved form 12 3.4 Latent form 12 4. The inhibitory mechanism of serpins 12 5. PAI-1 13 5.1 Expression 13 5.2 Inhibitory activity 13 5.3 Cofactors 14 5.3.1 heparin 14 5.3.2 vitronectin 14 5.4 Structural instability of PAI-1 14 5.5 Regulation of cell migration 15 5.6 Diseases related to PAI-1 15 6. Structure determination of proteins by fluorescence spectroscopy 15 6.1 Basic concept of fluorescence 16 6.2 Fluorescence lifetime 16 6.3 Fluorescence anisotropy 17 6.4 Energy transfer 17 6.5 Fluorescent probes 17 6.5.1 Intrinsic fluorophores 18 6.5.2 Extrinsic fluorophores 18 6.6 Donor-acceptor energy transfer (DAET) 18 6.7 Donor-Donor Energy Migration DDEM 19 6.8 Quenching of BODIPY dimmers 19 7. Summary of the present study 19 7.1 The use of site-directed fluorophore labeling and donor-donor energy migration to investigate solution structure and dynamics in proteins (Paper I) 19 7.2 Dimers of dipyrrometheneboron difluoride (BODIPY) with light spectroscopic applications in chemistry and biology. -
Proteinase K Dna Extraction Protocol
FT-85870n Proteinase K Product data Proteinase K, from Tritirachium album timber (Engyodontium album) Syn.: peptidase K, Tritirachium alkaline proteinase Protein K powder #858706 Proteinase K solution #718961 CAS: [ 39450-01-6 ] MW: 8,900 daltons (28.9 kDa). primary sequence for proteinase K: GAAQTNAPWGLARISSTSPGTSTYYYDESAGQGSCVYVIDTGIEASHPEF EGRAQMVKTYYYSSRDGNGHGTHCAGTVGSRTYGVAKKTQLFGVKVLDDN GSGQYSTIIAGMDFVASDKNNRNCPKGVVASLSLGGGYSSSVNSAAARLQ SSGVMVAVAAGNNNADARNYSPASEPSVCTVGASDRYDRRSSFSNYGSVL DIFGPGTSILSTWIGGSTRSISGTSMATPHVAGLAAYLMTLGKTTAASAC Proteinase K Protein Structure RYIADTANKGDLSNIPFGTVNLLAYNNYQA FAQ & Technical tips What is Proteinase K? PProteinase K (also protease K or endopeptidase K) is a broad-spectrum serine protease widely used in molecular biology. Proteinase K is able to digest native keratin (hair), hence, the name “Proteinase K”. It is commonly used because of its broad specificity, that makes it useful to clean nucleic acid complexe samples and to lyse cells. It has been used for isolation of mRNA, high molecular weight DNA and to inactivate other enzymatic activities. The enzyme was discovered in 1974 in extracts of the fungus Engyodontium album (formerly Tritirachium album). What are proteinase K applications? Proteinase K is ideal for many molecular biology applications because it is able to break down proteins and inactivate DNases and RNases that would otherwise degrade a desired sample of DNA or RNA. - Digestion of unwanted proteins in molecular biology applications - Removal of endotoxins bound to cationic proteins such as lysozyme and RNaseA - Removal of nucleases for in situ hybridization - Prion research with respect to TSE (transmissible spongiform encephalopathies) - Protease footprinting - Mitochontrial isolation - Isolation of genomic DNA - Isolation of cytoplasmic RNA - Isolation of highly native DNA or RNA Proteinase K is commonly used in molecular biology to digest protein and remove contamination from preparations of nucleic acid. -
Molecular Markers of Serine Protease Evolution
The EMBO Journal Vol. 20 No. 12 pp. 3036±3045, 2001 Molecular markers of serine protease evolution Maxwell M.Krem and Enrico Di Cera1 ment and specialization of the catalytic architecture should correspond to signi®cant evolutionary transitions in the Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, Box 8231, St Louis, history of protease clans. Evolutionary markers encoun- MO 63110-1093, USA tered in the sequences contributing to the catalytic apparatus would thus give an account of the history of 1Corresponding author e-mail: [email protected] an enzyme family or clan and provide for comparative analysis with other families and clans. Therefore, the use The evolutionary history of serine proteases can be of sequence markers associated with active site structure accounted for by highly conserved amino acids that generates a model for protease evolution with broad form crucial structural and chemical elements of applicability and potential for extension to other classes of the catalytic apparatus. These residues display non- enzymes. random dichotomies in either amino acid choice or The ®rst report of a sequence marker associated with serine codon usage and serve as discrete markers for active site chemistry was the observation that both AGY tracking changes in the active site environment and and TCN codons were used to encode active site serines in supporting structures. These markers categorize a variety of enzyme families (Brenner, 1988). Since serine proteases of the chymotrypsin-like, subtilisin- AGY®TCN interconversion is an uncommon event, it like and a/b-hydrolase fold clans according to phylo- was reasoned that enzymes within the same family genetic lineages, and indicate the relative ages and utilizing different active site codons belonged to different order of appearance of those lineages. -
Gene Expression of Prohormone and Proprotein Convertases in the Rat CNS: a Comparative in Situ Hybridization Analysis
The Journal of Neuroscience, March 1993. 73(3): 1258-1279 Gene Expression of Prohormone and Proprotein Convertases in the Rat CNS: A Comparative in situ Hybridization Analysis Martin K.-H. Schafer,i-a Robert Day,* William E. Cullinan,’ Michel Chri?tien,3 Nabil G. Seidah,* and Stanley J. Watson’ ‘Mental Health Research Institute, University of Michigan, Ann Arbor, Michigan 48109-0720 and J. A. DeSeve Laboratory of *Biochemical and 3Molecular Neuroendocrinology, Clinical Research Institute of Montreal, Montreal, Quebec, Canada H2W lR7 Posttranslational processing of proproteins and prohor- The participation of neuropeptides in the modulation of a va- mones is an essential step in the formation of bioactive riety of CNS functions is well established. Many neuropeptides peptides, which is of particular importance in the nervous are synthesized as inactive precursor proteins, which undergo system. Following a long search for the enzymes responsible an enzymatic cascade of posttranslational processing and mod- for protein precursor cleavage, a family of Kexin/subtilisin- ification events during their intracellular transport before the like convertases known as PCl, PC2, and furin have recently final bioactive products are secreted and act at either pre- or been characterized in mammalian species. Their presence postsynaptic receptors. Initial endoproteolytic cleavage occurs in endocrine and neuroendocrine tissues has been dem- C-terminal to pairs of basic amino acids such as lysine-arginine onstrated. This study examines the mRNA distribution of (Docherty and Steiner, 1982) and is followed by the removal these convertases in the rat CNS and compares their ex- of the basic residues by exopeptidases. Further modifications pression with the previously characterized processing en- can occur in the form of N-terminal acetylation or C-terminal zymes carboxypeptidase E (CPE) and peptidylglycine a-am- amidation, which is essential for the bioactivity of many neu- idating monooxygenase (PAM) using in situ hybridization ropeptides. -
Human Proprotein Convertase 9/PCSK9 Quantikine
Quantikine® ELISA Human Proprotein Convertase 9/PCSK9 Immunoassay Catalog Number DPC900 Catalog Number SPC900 Catalog Number PDPC900 For the quantitative determination of human Proprotein Convertase Subtilisin Kexin 9 (PCSK9) concentrations in cell culture supernates, cell lysates, serum, and plasma. This package insert must be read in its entirety before using this product. For research use only. Not for use in diagnostic procedures. TABLE OF CONTENTS SECTION PAGE INTRODUCTION .....................................................................................................................................................................1 PRINCIPLE OF THE ASSAY ...................................................................................................................................................2 LIMITATIONS OF THE PROCEDURE .................................................................................................................................2 TECHNICAL HINTS .................................................................................................................................................................2 MATERIALS PROVIDED & STORAGE CONDITIONS ...................................................................................................3 PHARMPAK CONTENTS .......................................................................................................................................................4 OTHER SUPPLIES REQUIRED .............................................................................................................................................5 -
Human Alpha 2 Antiplasmin (Total) ELISA Kit (ARG81079)
Product datasheet [email protected] ARG81079 Package: 96 wells Human alpha 2 Antiplasmin (total) ELISA Kit Store at: 4°C Summary Product Description ARG81079 alpha 2 Human Antiplasmin (total) ELISA Kit is an Enzyme Immunoassay kit for the quantification of Human Antiplasmin (total) in plasma. Tested Reactivity Hu Tested Application ELISA Target Name alpha 2 Antiplasmin Conjugation HRP Conjugation Note TMB substrate is used for color development at 450 nm. Sensitivity 0.028 ng/ml Sample Type Plasma Standard Range 0.1 - 100 ng/ml Alternate Names Alpha-2-AP; Serpin F2; Alpha-2-PI; Alpha-2-antiplasmin; Alpha-2-plasmin inhibitor; AAP; API; PLI; A2AP; ALPHA-2-P Properties Form 96 well Storage instruction Store the kit at 2-8°C. Keep microplate wells sealed in a dry bag with desiccants. Do not expose test reagents to heat, sun or strong light during storage and usage. Please refer to the product user manual for detail temperatures of the components. Note For laboratory research only, not for drug, diagnostic or other use. Bioinformation Database links GeneID: 5345 Human Swiss-port # P08697 Human Gene Symbol SERPINF2 Gene Full Name serpin family F member 2 Background This gene encodes a member of the serpin family of serine protease inhibitors. The protein is a major inhibitor of plasmin, which degrades fibrin and various other proteins. Consequently, the proper function of this gene has a major role in regulating the blood clotting pathway. Mutations in this gene result in alpha-2-plasmin inhibitor deficiency, which is characterized by severe hemorrhagic diathesis. Multiple transcript variants encoding different isoforms have been found for this gene. -
The Plasmin–Antiplasmin System: Structural and Functional Aspects
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Bern Open Repository and Information System (BORIS) Cell. Mol. Life Sci. (2011) 68:785–801 DOI 10.1007/s00018-010-0566-5 Cellular and Molecular Life Sciences REVIEW The plasmin–antiplasmin system: structural and functional aspects Johann Schaller • Simon S. Gerber Received: 13 April 2010 / Revised: 3 September 2010 / Accepted: 12 October 2010 / Published online: 7 December 2010 Ó Springer Basel AG 2010 Abstract The plasmin–antiplasmin system plays a key Plasminogen activator inhibitors Á a2-Macroglobulin Á role in blood coagulation and fibrinolysis. Plasmin and Multidomain serine proteases a2-antiplasmin are primarily responsible for a controlled and regulated dissolution of the fibrin polymers into solu- Abbreviations ble fragments. However, besides plasmin(ogen) and A2PI a2-Antiplasmin, a2-Plasmin inhibitor a2-antiplasmin the system contains a series of specific CHO Carbohydrate activators and inhibitors. The main physiological activators EGF-like Epidermal growth factor-like of plasminogen are tissue-type plasminogen activator, FN1 Fibronectin type I which is mainly involved in the dissolution of the fibrin K Kringle polymers by plasmin, and urokinase-type plasminogen LBS Lysine binding site activator, which is primarily responsible for the generation LMW Low molecular weight of plasmin activity in the intercellular space. Both activa- a2M a2-Macroglobulin tors are multidomain serine proteases. Besides the main NTP N-terminal peptide of Pgn physiological inhibitor a2-antiplasmin, the plasmin–anti- PAI-1, -2 Plasminogen activator inhibitor 1, 2 plasmin system is also regulated by the general protease Pgn Plasminogen inhibitor a2-macroglobulin, a member of the protease Plm Plasmin inhibitor I39 family. -
Antiplasmin the Main Plasmin Inhibitor in Blood Plasma
1 From Department of Surgical Sciences, Division of Clinical Chemistry and Blood Coagu- lation, Karolinska University Hospital, Karolinska Institutet, S-171 76 Stockholm, Sweden ANTIPLASMIN THE MAIN PLASMIN INHIBITOR IN BLOOD PLASMA Studies on Structure-Function Relationships Haiyao Wang Stockholm 2005 2 ABSTRACT ANTIPLASMIN THE MAIN PLASMIN INHIBITOR IN BLOOD PLASMA Studies on Structure-Function Relationships Haiyao Wang Department of Surgical Sciences, Division of Clinical Chemistry and Blood Coagulation, Karo- linska University Hospital, Karolinska Institute, S-171 76 Stockholm, Sweden Antiplasmin is an important regulator of the fibrinolytic system. It inactivates plasmin very rapidly. The reaction between plasmin and antiplasmin occurs in several steps: first a lysine- binding site in plasmin interacts with a complementary site in antiplasmin. Then, an interac- tion occurs between the substrate-binding pocket in the plasmin active site and the scissile peptide bond in the RCL of antiplasmin. Subsequently, peptide bond cleavage occurs and a stable acyl-enzyme complex is formed. It has been accepted that the COOH-terminal lysine residue in antiplasmin is responsible for its interaction with the plasmin lysine-binding sites. In order to identify these structures, we constructed single-site mutants of charged amino ac- ids in the COOH-terminal portion of antiplasmin. We found that modification of the COOH- terminal residue, Lys452, did not change the activity or the kinetic properties significantly, suggesting that Lys452 is not involved in the lysine-binding site mediated interaction between plasmin and antiplasmin. On the other hand, modification of Lys436 to Glu decreased the reaction rate significantly, suggesting this residue to have a key function in this interaction. -
Overexpression of Plasminogen Activator Inhibitor Type 2 in Basal Keratinocytes Enhances Papilloma Formation in Transgenic Mice1
[CANCER RESEARCH 61, 970–976, February 1, 2001] Overexpression of Plasminogen Activator Inhibitor Type 2 in Basal Keratinocytes Enhances Papilloma Formation in Transgenic Mice1 Hong-Ming Zhou, Isabelle Bolon, Anthony Nichols,2 Annelise Wohlwend, and Jean-Dominique Vassalli3 Department of Morphology, University of Geneva Medical School, CH-1211 Geneva 4, Switzerland ABSTRACT PAI-1 is expressed more broadly than PAI-2, and its role in modu- lating extracellular proteolysis has been demonstrated by ablation (2) The serpin plasminogen activator inhibitor (PAI) type 2 is expressed in or overexpression (3) of the PAI-1 gene. Although PAI-2 can inhibit differentiated epidermal keratinocytes. To explore its role in this tissue, extracellular uPA and tPA (the two-chain form; Ref. 4), it may have we studied the impact of PAI-2 overexpression on epidermal differentia- tion and skin carcinogenesis. A mouse PAI-2-encoding transgene was additional intracellular functions: it is found in both a secreted and an targeted to basal epidermis and hair follicles under the control of the intracellular cytosolic form, both of which result from translation of bovine keratin type 5 gene promoter. Two mouse lines were established, the same mRNA; and their antiprotease activity is similar (5–7). Hints one of which strongly expressed the transgene and produced elevated regarding the possible functions of intracellular PAI-2 have come levels of PAI-2 in the epidermis. Although it had no manifest impact on from the observations that induction of endogenous PAI-2 or -
Genome Wide Identification and Comparative Analysis of the Serpin
plants Article Genome Wide Identification and Comparative Analysis of the Serpin Gene Family in Brachypodium and Barley Shazia Rehman 1,2,3,* , Bodil Jørgensen 3, Ejaz Aziz 4, Riffat Batool 5, Samar Naseer 6 and Søren K. Rasmussen 3,* 1 Department of Botany, Rawalpindi Women University, 6th Road, Satellite Town, Rawalpindi 46200, Pakistan 2 Department of Botany, Govt. Gordon College Rawalpindi, Rawalpindi 46000, Pakistan 3 Department of Plant and Environmental Sciences, Faculty of Sciences, University of Copenhagen, 1871 Frederiksberg C, Denmark; [email protected] 4 Department of Botany, Government Degree College Khanpur, Haripur 22650, Pakistan; [email protected] 5 University Institute of Biochemistry and Biotechnology, PMAS, Arid Agriculture University, Rawalpindi, Rawalpindi 46300, Pakistan; riff[email protected] 6 Department of Biology and Environmental Science, Faculty of Sciences, Allama Iqbal Open University, Islamabad 44000, Pakistan; [email protected] * Correspondence: [email protected] (S.R.); [email protected] (S.K.R.) Received: 3 October 2020; Accepted: 15 October 2020; Published: 26 October 2020 Abstract: Serpins (serine protease inhibitors) constitute one of the largest and most widely distributed superfamilies of protease inhibitors and have been identified in nearly all organisms. To gain significant insights, a comprehensive in silico analysis of the serpin gene family was carried out in the model plant for temperate grasses Brachypodium distachyon and barley Hordeum vulgare using bioinformatic tools at the genome level for the first time. We identified a total of 27 BdSRPs and 25 HvSRP genes in Brachypodium and barley, respectively, showing an unexpectedly high gene number in these model plants. Gene structure, conserved motifs and phylogenetic comparisons of serpin genes supported the role of duplication events in the expansion and evolution of serpin gene family. -
A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: to Target Or Not to Target?
International Journal of Molecular Sciences Review A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: To Target or Not to Target? Machteld Sillen and Paul J. Declerck * Laboratory for Therapeutic and Diagnostic Antibodies, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, B-3000 Leuven, Belgium; [email protected] * Correspondence: [email protected] Abstract: Plasminogen activator inhibitor-1 (PAI-1) is the main physiological inhibitor of plasminogen activators (PAs) and is therefore an important inhibitor of the plasminogen/plasmin system. Being the fast-acting inhibitor of tissue-type PA (tPA), PAI-1 primarily attenuates fibrinolysis. Through inhibition of urokinase-type PA (uPA) and interaction with biological ligands such as vitronectin and cell-surface receptors, the function of PAI-1 extends to pericellular proteolysis, tissue remodeling and other processes including cell migration. This review aims at providing a general overview of the properties of PAI-1 and the role it plays in many biological processes and touches upon the possible use of PAI-1 inhibitors as therapeutics. Keywords: plasminogen activator inhibitor-1; PAI-1; fibrinolysis; cardiovascular disease; cancer; inflammation; fibrosis; aging Citation: Sillen, M.; Declerck, P.J. 1. Introduction A Narrative Review on Plasminogen Plasminogen activator inhibitor-1 (PAI-1) belongs to the family of serine protease Activator Inhibitor-1 and Its inhibitors (serpins) and is an important regulator of the plasminogen/plasmin system (Patho)Physiological Role: To Target (Figure1)[ 1]. This system revolves around the conversion of the zymogen plasmino- or Not to Target?. Int. J. Mol. Sci. 2021, gen into the active enzyme plasmin through proteolytic cleavage that is mediated by 22, 2721.